Non-Steroidal Anti Inflammatory Drugs is the class of analgesics which distinguished by their non-steroidal chemical structure. These are used to reduce pain caused due to inflammation. It is first line treatment in pain management due to their special properties such as antipyretic, analgesic, and anti-inflammatory.
Market Drivers
Increase in bone and joint pain diseases such as osteoarthritis, and rheumatoid arthritis among individuals is the key driving factor which is expected to boost the global Non-Steroidal Anti Inflammatory Drugs market growth. Furthermore, rise in number of surgeries will have the positive impact on market growth. Moreover, rise in geriatric population and high risk of various diseases will fuel the market growth. Also, adoption of pain management therapeutics among end users will drive the market growth during this forecast period.
However, availability of new innovative therapeutic analgesics is the major restraining factor which is expected to hamper the global Non-Steroidal Anti Inflammatory Drugs market growth. Also, stringent government rules and regulations will affect the market growth.
Global Non-Steroidal Anti Inflammatory Drugs Market is segmented into type such as Ibuprofen, Aspirin, Naproxen, Nabumetone, and Others. Further, market is segmented into application such as Back Pain Treatment, Osteoarthritis Treatment, and Others.
Also, Global Non-Steroidal Anti Inflammatory Drugs Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are discussed in this report such as GlaxoSmithKline, Johnson and Johnson, Pfizer Inc, Kopran Ltd, Bayer (DE), Abbott, Novacap (FR), Perrigo Company, and Sun Pharmaceutical Industries Ltd
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
5.2 Global Non-Steroidal Anti Inflammatory Drugs Market Share Analysis, By Type
5.3 Global Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Type
5.3.1 Ibuprofen
5.3.2 Aspirin
5.3.3Naproxen
5.3.4Nabumetone
5.3.5 Others
6.2 Global Non-Steroidal Anti Inflammatory Drugs Market Share Analysis, By Application
6.3 Global Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Application
6.3.1 Back Pain Treatment
6.3.2 Osteoarthritis Treatment
6.3.3Others
7.2 Global Non-Steroidal Anti Inflammatory Drugs Market Share Analysis, By Region
7.3 Global Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Region
8.2 North America Non-Steroidal Anti Inflammatory Drugs Market Share Analysis, By Type
8.3 North America Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Application
8.4 North America Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Country
8.4.1 U.S
8.4.2 Canada
8.4.3 Mexico
9.2 Europe Non-Steroidal Anti Inflammatory Drugs Market Share Analysis, By Type
9.3 Europe Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Application
9.4 Europe Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4. Rest of Europe
10.2 Asia Pacific Non-Steroidal Anti Inflammatory Drugs Market Share Analysis, By Type
10.3 Asia Pacific Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Application
10.4 Asia Pacific Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11.2 Latin America Non-Steroidal Anti Inflammatory Drugs Market Share Analysis, By Type
11.3 Latin America Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Application
11.4 Latin America Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Country
12.2 Middle East Non-Steroidal Anti Inflammatory Drugs Market Share Analysis, By Type
12.3 Middle East Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Application
12.4 Middle East Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Country
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
